Description

The design of the new 'MIKS-ROSCARDIKS' valves is in mass production and broadly implanting in clinics now. It was patented in the USA — US 6,569,197 B2 May 27, 2003.

The main advantages of 'MIKS-ROSCARDIKS' valves in comparison with well known foreign brands are the following:

- Haemodynamic effectiveness;
- Total wash of the valve elements with blood.

The high quality and reliability of heart valves manufacture and technology based on the Certificate of Safety and the License issued to ’Roskardioinvest’ after a wide range of testing.

Since the 'MIKS-ROSCARDIKS' valves are in use there were no failures because of its mechanical dysfunction neither during implantation nor after it.